Craniofacial and central nervous system malformations induced by triamcinolone acetonide in nonhuman primates: II. Craniofacial pathogenesis

R. M. Parker, Andrew G Hendrickx

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

This study further defines the craniofacial malformations induced by triamcinolone acetonide in the rhesus monkey. Ten timed‐mated pregnant rhesus monkeys (Macaca mulatta) received intramuscular injections of 10 mg/kg TAC on days 23, 25, 27, 29, and 31 of gestation. Results of previous experiments with rhesus and bonnet monkeys and baboons indicated that specific craniofacial and brain malformations could be induced with TAC during this period of pregnancy (Hendrickx et al., '80). Stage‐matched TAC‐treated and control embryos (stages 17–18 and 22) and age‐matched TAC‐treated and control fetuses (50, 60, and 70 days gestation) were removed by hysterotomy. Stage 17–18 TAC embryos appeared grossly normal but histologic evaluation revealed a shortened anlage of the posterior cranial base. Stage 22 TAC embryos and all TAC fetuses exhibited craniofacial dysmorphia and encephalocele. The developing sphenoid was the earliest affected and most severely malformed bone. Its defects included reduced anterioposterior and transverse dimensions, reduced orbitosphenoid and alisphenoid, abnormal pituitary fossa, and reduced dorsum and tuberculum sellae. In addition, shortening of the posterior cranial base and decreased cranial base angle was a consistent finding in the treated embryos and fetuses. Decreased ossification and remodeling in the facial bones and abnormal position due to the malformed sphenoid occurred.

Original languageEnglish (US)
Pages (from-to)35-44
Number of pages10
JournalTeratology
Volume28
Issue number1
DOIs
StatePublished - 1983

Fingerprint

Nervous System Malformations
Triamcinolone Acetonide
Neurology
Macaca mulatta
Primates
Skull Base
Bone
Embryonic Structures
Central Nervous System
Fetus
Pregnancy
Brain
Macaca radiata
Hysterotomy
Facial Bones
Encephalocele
Defects
Papio
Intramuscular Injections
Osteogenesis

ASJC Scopus subject areas

  • Embryology
  • Toxicology
  • Developmental Biology
  • Health, Toxicology and Mutagenesis

Cite this

Craniofacial and central nervous system malformations induced by triamcinolone acetonide in nonhuman primates : II. Craniofacial pathogenesis. / Parker, R. M.; Hendrickx, Andrew G.

In: Teratology, Vol. 28, No. 1, 1983, p. 35-44.

Research output: Contribution to journalArticle

@article{9dc75193aab242a2ae280d1a529b4122,
title = "Craniofacial and central nervous system malformations induced by triamcinolone acetonide in nonhuman primates: II. Craniofacial pathogenesis",
abstract = "This study further defines the craniofacial malformations induced by triamcinolone acetonide in the rhesus monkey. Ten timed‐mated pregnant rhesus monkeys (Macaca mulatta) received intramuscular injections of 10 mg/kg TAC on days 23, 25, 27, 29, and 31 of gestation. Results of previous experiments with rhesus and bonnet monkeys and baboons indicated that specific craniofacial and brain malformations could be induced with TAC during this period of pregnancy (Hendrickx et al., '80). Stage‐matched TAC‐treated and control embryos (stages 17–18 and 22) and age‐matched TAC‐treated and control fetuses (50, 60, and 70 days gestation) were removed by hysterotomy. Stage 17–18 TAC embryos appeared grossly normal but histologic evaluation revealed a shortened anlage of the posterior cranial base. Stage 22 TAC embryos and all TAC fetuses exhibited craniofacial dysmorphia and encephalocele. The developing sphenoid was the earliest affected and most severely malformed bone. Its defects included reduced anterioposterior and transverse dimensions, reduced orbitosphenoid and alisphenoid, abnormal pituitary fossa, and reduced dorsum and tuberculum sellae. In addition, shortening of the posterior cranial base and decreased cranial base angle was a consistent finding in the treated embryos and fetuses. Decreased ossification and remodeling in the facial bones and abnormal position due to the malformed sphenoid occurred.",
author = "Parker, {R. M.} and Hendrickx, {Andrew G}",
year = "1983",
doi = "10.1002/tera.1420280107",
language = "English (US)",
volume = "28",
pages = "35--44",
journal = "Teratology",
issn = "1542-0752",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Craniofacial and central nervous system malformations induced by triamcinolone acetonide in nonhuman primates

T2 - II. Craniofacial pathogenesis

AU - Parker, R. M.

AU - Hendrickx, Andrew G

PY - 1983

Y1 - 1983

N2 - This study further defines the craniofacial malformations induced by triamcinolone acetonide in the rhesus monkey. Ten timed‐mated pregnant rhesus monkeys (Macaca mulatta) received intramuscular injections of 10 mg/kg TAC on days 23, 25, 27, 29, and 31 of gestation. Results of previous experiments with rhesus and bonnet monkeys and baboons indicated that specific craniofacial and brain malformations could be induced with TAC during this period of pregnancy (Hendrickx et al., '80). Stage‐matched TAC‐treated and control embryos (stages 17–18 and 22) and age‐matched TAC‐treated and control fetuses (50, 60, and 70 days gestation) were removed by hysterotomy. Stage 17–18 TAC embryos appeared grossly normal but histologic evaluation revealed a shortened anlage of the posterior cranial base. Stage 22 TAC embryos and all TAC fetuses exhibited craniofacial dysmorphia and encephalocele. The developing sphenoid was the earliest affected and most severely malformed bone. Its defects included reduced anterioposterior and transverse dimensions, reduced orbitosphenoid and alisphenoid, abnormal pituitary fossa, and reduced dorsum and tuberculum sellae. In addition, shortening of the posterior cranial base and decreased cranial base angle was a consistent finding in the treated embryos and fetuses. Decreased ossification and remodeling in the facial bones and abnormal position due to the malformed sphenoid occurred.

AB - This study further defines the craniofacial malformations induced by triamcinolone acetonide in the rhesus monkey. Ten timed‐mated pregnant rhesus monkeys (Macaca mulatta) received intramuscular injections of 10 mg/kg TAC on days 23, 25, 27, 29, and 31 of gestation. Results of previous experiments with rhesus and bonnet monkeys and baboons indicated that specific craniofacial and brain malformations could be induced with TAC during this period of pregnancy (Hendrickx et al., '80). Stage‐matched TAC‐treated and control embryos (stages 17–18 and 22) and age‐matched TAC‐treated and control fetuses (50, 60, and 70 days gestation) were removed by hysterotomy. Stage 17–18 TAC embryos appeared grossly normal but histologic evaluation revealed a shortened anlage of the posterior cranial base. Stage 22 TAC embryos and all TAC fetuses exhibited craniofacial dysmorphia and encephalocele. The developing sphenoid was the earliest affected and most severely malformed bone. Its defects included reduced anterioposterior and transverse dimensions, reduced orbitosphenoid and alisphenoid, abnormal pituitary fossa, and reduced dorsum and tuberculum sellae. In addition, shortening of the posterior cranial base and decreased cranial base angle was a consistent finding in the treated embryos and fetuses. Decreased ossification and remodeling in the facial bones and abnormal position due to the malformed sphenoid occurred.

UR - http://www.scopus.com/inward/record.url?scp=0020523373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020523373&partnerID=8YFLogxK

U2 - 10.1002/tera.1420280107

DO - 10.1002/tera.1420280107

M3 - Article

C2 - 6635997

AN - SCOPUS:0020523373

VL - 28

SP - 35

EP - 44

JO - Teratology

JF - Teratology

SN - 1542-0752

IS - 1

ER -